secwatch.observer — SEC 8-K summary
======================================

Issuer:     IONIS PHARMACEUTICALS INC (IONS)
CIK:        0000874015
Form:       8-K/A
Filed at:   2025-11-03T23:59:59+00:00
Accession:  0001140361-25-040220
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ionis enters advisory agreement with retiring executive Richard Geary
---------------------------------------------------------------------

- Advisory Services Agreement with Richard Geary effective Jan 16, 2026 through Feb 13, 2027.
- Total fee of $300,000, plus up to $400/hour for hours over 16/week, capped at $450,000 total.
- Geary will provide up to 16 hours/week of advisory services following retirement from Ionis.
- Agreement includes standard confidentiality, non-solicitation, and invention assignment clauses.
- Either party may terminate with 15 days' written notice; equity acceleration triggered on change in control.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/874015/000114036125040220/0001140361-25-040220-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/874015/000114036125040220/ef20058178_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-040220

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer